Impact of adenovirus life cycle progression on the generation of canine helper-dependent vectors

Gene Therapy

Volumn 22, Issue 1, 2015, Pages 40-49

  Fernandes, P ^a,b   Simao D ^a,b   Guerreiro, M R ^a,b   Kremer, E J ^c   Coroadinha, A S ^a,b   Alves, P M ^a,b  

^a INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; AUTOPHAGY; CELL CYCLE PROGRESSION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; DNA REPLICATION; HELPER DEPENDENT ADENOVIRUS; HUMAN; INFECTION CONTROL; LIFE CYCLE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; ANIMAL; CANINE ADENOVIRUS; CELL SURVIVAL; DOG; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; MDCK CELL LINE; PHYSIOLOGY;

ADENOVIRIDAE; CANINE ADENOVIRUS TYPE 2; MIRIDAE;

ADENOVIRUSES, CANINE; ANIMALS; AUTOPHAGY; CELL SURVIVAL; DNA REPLICATION; DOGS; GENETIC THERAPY; GENETIC VECTORS; GENOME, VIRAL; MADIN DARBY CANINE KIDNEY CELLS; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 84920547501     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2014.92     Document Type: Article

References (56)

1. Lowenstein PR, Mandel RJ, Xiong WD, Kroeger K, Castro MG. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions. Curr Gene Ther 2007; 7: 347-360.
2. Kremer EJ, Boutin S, Chillon M, Danos O. Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 2000; 74: 505-512.
3. Perreau M, Kremer EJ. Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus. J Virol 2005; 79: 14595-14605.
4. Keriel A, Rene C, Galer C, Zabner J, Kremer EJ. Canine adenovirus vectors for lungdirected gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors. J Virol 2006; 80: 1487-1496.
5. Perreau M, Mennechet F, Serratrice N, Glasgow JN, Curiel DT, Wodrich H et al. Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy. J Virol 2007; 81: 3272-3284.
6. Soudais C, Laplace-Builhe C, Kissa K, Kremer EJ. Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo. FASEB J 2001; 15: 2283-2285.
7. Soudais C, Skander N, Kremer EJ. Long-term in vivo transduction of neurons throughout the rat CNS using novel helper-dependent CAV-2 vectors. FASEB J 2004; 18: 391-393.
8. Cubizolle A, Serratrice N, Skander N, Colle MA, Ibanes S, Gennetier A et al. Corrective GUSB transfer to the canine Mucopolysaccharidosis VII brain. Mol Ther 2014; 22: 762-773.
9. Ariza L, Gimenez-Llort L, Cubizolle A, Pages G, Garcia-Lareu B, Serratrice N et al. Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in Mucopolysaccharidosis type VII mice. Hum Gene Ther 2014; 25: 199-211.
10. Dormond E, Perrier M, Kamen A. From the first to the third generation adenoviral vector: what parameters are governing the production yield? Biotechnol Adv 2009; 27: 133-144.
11. Ng P, Beauchamp C, Evelegh C, Parks R, Graham FL. Development of a FLP/frt system for generating helper-dependent adenoviral vectors. Mol Ther 2001; 3: 809-815.
12. Umana P, Gerdes CA, Stone D, Davis JR, Ward D, Castro MG et al. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nat Biotechnol 2001; 19: 582-585.
13. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 1996; 93: 13565-13570.
14. Gonzalez-Aparicio M, Mauleon I, Alzuguren P, Bunuales M, Gonzalez-Aseguinolaza G, San Martin C et al. Self-inactivating helper virus for the production of highcapacity adenoviral vectors. Gene Therapy 2011; 18: 1025-1033.
15. Alba R, Hearing P, Bosch A, Chillon M. Differential amplification of adenovirus vectors by flanking the packaging signal with attB/attP-PhiC31 sequences: implications for helper-dependent adenovirus production. Virology 2007; 367: 51-58.
16. Soudais C, Boutin S, Kremer EJ. Characterization of cis-acting sequences involved in canine adenovirus packaging. Mol Ther 2001; 3: 631-640.
17. Kanegae Y, Ishimura M, Kondo S, Saito I. Influence of loxP insertion upstream of the cis-acting packaging domain on adenovirus packaging efficiency. Microbiol Immunol 2012; 56: 447-455.
18. Hartigan-O'Connor D, Amalfitano A, Chamberlain JS. Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase. J Virol 1999; 73: 7835-7841.
19. Dormond E, Meneses-Acosta A, Jacob D, Durocher Y, Gilbert R, Perrier M et al. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection. Biotechnol Bioeng 2009; 102: 800-810.
20. Ibanes S, Kremer EJ. Canine adenovirus type 2 vector generation via I-Sce1-mediated intracellular genome release. PLoS One 2013; 8: e71032.
21. Palmer D, Ng P. Improved system for helper-dependent adenoviral vector production. Mol Ther 2003; 8: 846-852.
22. Suzuki M, Cela R, Clarke C, Bertin TK, Mourino S, Lee B. Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories. Hum Gene Ther 2010; 21: 120-126.
23. Kreppel F, Biermann V, Kochanek S, Schiedner G. A DNA-based method to assay total and infectious particle contents and helper virus contamination in highcapacity adenoviral vector preparations. Hum Gene Ther 2002; 13: 1151-1156.
24. Flint SJ, Enquist LW, Racaniello VR, Skalka AM. Principles of Virology: Molecular Biology, Pathogenesis, and Control of Animal Viruses, 2nd edn. ASM Press: Washington, DC, 2004.
25. Greber UF, Suomalainen M, Stidwill RP, Boucke K, Ebersold MW, Helenius A. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J 1997; 16: 5998-6007.
26. Perez-Berna AJ, Ortega-Esteban A, Menendez-Conejero R, Winkler DC, Menendez M, Steven AC et al. The role of capsid maturation on adenovirus priming for sequential uncoating. J Biol Chem 2012; 287: 31582-31595.
27. Graziano V, McGrath WJ, Suomalainen M, Greber UF, Freimuth P, Blainey PC et al. Regulation of a viral proteinase by a peptide and DNA in one-dimensional space: I. Binding to DNA AND to hexon of the precursor to protein VI, pVI, of human adenovirus. J Biol Chem 2013; 288: 2059-2067.
28. Blainey PC, Graziano V, Perez-Berna AJ, McGrath WJ, Flint SJ, San Martin C et al. Regulation of a viral proteinase by a peptide and DNA in one-dimensional space: IV. Viral proteinase slides along DNA to locate and process its substrates. J Biol Chem 2013; 288: 2092-2102.
29. Kamen A, Henry O. Development and optimization of an adenovirus production process. J Gene Med 2004; 6: 184-192.
30. Swaminathan S, Thimmapaya B. Regulation of adenovirus E2 transcription Uuit. In: Doerfler W, Böhm P (eds) The Molecular Repertoire of Adenoviruses III vol. 199/3. Springer: Berlin, Heidelberg, 1995, pp 177-194.
31. Weber J. Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J Virol 1976; 17: 462-471.
32. Tribouley C, Lutz P, Staub A, Kedinger C. The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter. J Virol 1994; 68: 4450-4457.
33. Zhang W, Low JA, Christensen JB, Imperiale MJ. Role for the adenovirus IVa2 protein in packaging of viral DNA. J Virol 2001; 75: 10446-10454.
34. Altaras NE, Aunins JG, Evans RK, Kamen A, Konz JO, Wolf JJ. Production and formulation of adenovirus vectors. Adv Biochem Eng Biotechnol 2005; 99: 193-260.
35. Jiang H, White EJ, Rios-Vicil CI, Xu J, Gomez-Manzano C, Fueyo J. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol 2011; 85: 4720-4729.
36. Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, Rao XM, Chen L, McMasters KM et al. Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology 2011; 416: 9-15.
37. Nevins JR. Regulation of early adenovirus gene expression. Microbiol Rev 1987; 51: 419-430.
38. Ross PJ, Kennedy MA, Parks RJ. Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression. J Virol 2009; 83: 8409-8417.
39. Parks RJ, Bramson JL, Wan Y, Addison CL, Graham FL. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. J Virol 1999; 73: 8027-8034.
40. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2001; 2: 211-216.
41. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Developmental cell 2004; 6: 463-477.
42. Baehrecke EH. Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 2005; 6: 505-510.
43. Gozuacik D, Kimchi A. Autophagy and cell death. Curr Topics Dev Biol 2007; 78: 217-245.
44. Ostapchuk P, Hearing P. Control of adenovirus packaging. J Cell Biochem 2005; 96: 25-35.
45. Perez-Romero P, Gustin KE, Imperiale MJ. Dependence of the encapsidation function of the adenovirus L1 52/55-kilodalton protein on its ability to bind the packaging sequence. J Virol 2006; 80: 1965-1971.
46. Ostapchuk P, Anderson ME, Chandrasekhar S, Hearing P. The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome. J Virol 2006; 80: 6973-6981.
47. Ma HC, Hearing P. Adenovirus structural protein IIIa is involved in the serotype specificity of viral DNA packaging. J Virol 2011; 85: 7849-7855.
48. Erturk E, Ostapchuk P, Wells SI, Yang J, Gregg K, Nepveu A et al. Binding of CCAAT displacement protein CDP to adenovirus packaging sequences. J Virol 2003; 77: 6255-6264.
49. Mangel WF, McGrath WJ, Toledo DL, Anderson CW. Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature 1993; 361: 274-275.
50. Chen PH, Ornelles DA, Shenk T. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J Virol 1993; 67: 3507-3514.
51. Fernandes P, Santiago VM, Rodrigues AF, Tomas H, Kremer EJ, Alves PM et al. Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines. PLoS One 2013; 8: e60342.
52. Kramberger P, Ciringer M, Strancar A, Peterka M. Evaluation of nanoparticle tracking analysis for total virus particle determination. Virol J 2012; 9: 265.
53. Serra M, Leite SB, Brito C, Costa J, Carrondo MJ, Alves PM. Novel culture strategy for human stem cell proliferation and neuronal differentiation. J Neurosci Res 2007; 85: 3557-3566.
54. Salinas S, Bilsland LG, Henaff D, Weston AE, Keriel A, Schiavo G et al. CARassociated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathogens 2009; 5: e1000442.
55. Russell WC. Update on adenovirus and its vectors. J Gen Virol 2000; 81(Pt 11): 2573-2604.
56. Weitzman MD, Ornelles DA. Inactivating intracellular antiviral responses during adenovirus infection. Oncogene 2005; 24: 7686-7696.